Quadrature Capital’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-6,075
Closed -$565K – 1550
2026
Q1
$565K Buy
+6,075
New +$538K 0.01% 751
2022
Q3
– Sell
-6,709
Closed -$368K – 836
2022
Q2
$368K Buy
+6,709
New +$389K 0.02% 488
2021
Q1
– Sell
-7,313
Closed -$213K – 844
2020
Q4
$213K Sell
7,313
-11,545
-61% -$299K 0.01% 704
2020
Q3
$415K Buy
18,858
+5,534
+42% +$141K 0.02% 514
2020
Q2
$370K Buy
+13,324
New +$325K 0.04% 440
2018
Q1
– Sell
-17,780
Closed -$510K – 574
2017
Q4
$510K Buy
+17,780
New +$559K 0.05% 327
2017
Q3
– Sell
-18,153
Closed -$380K – 422
2017
Q2
$380K Buy
+18,153
New +$384K 0.03% 405

Other funds holding ACLS

Quadrature Capital's ACLS Position: Q2 2026 in Review

Quadrature Capital sold out of Axcelis (ACLS) in Q2 2026, closing a stake of 6,075 shares — an estimated $565K sold.

Quadrature Capital first reported a position in ACLS in Q2 2017 and held it in 7 quarters. The position peaked at $565K in Q1 2026. 443 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Quadrature Capital reported no remaining Axcelis position as of Q2 2026 after selling out during the quarter.
  • Quadrature Capital sold 6,075 Axcelis shares in Q2 2026, an estimated $565K.
  • Quadrature Capital first reported a position in Axcelis in Q2 2017 and held it in 7 quarters.
  • Quadrature Capital's Axcelis position peaked at $565K in Q1 2026.
  • 443 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.